Amniox Medical Brings Revolutionary Amniotic Membrane Technology to the Forefront of Podiatry

Amniox Medical Brings Revolutionary Amniotic Membrane Technology to the Forefront of Podiatry Amniox Medical Press Release Amniox launching NEOXTM Grafts at the American College of Foot and Ankle Surgeons Annual Scientific Conference Amniox Medical, Inc., a leader in Amnion regenerative tissue therapies, will introduce their NEOXTM Grafts at the 2012 Annual Scientific Conference of the American College of Foot and Ankle Surgeons (ACFAS) in San Antonio, Texas on March 1- 3. Conference attendees can visit them at Booth # 566. The 2012 ACFAS will be the inaugural attendance for Amniox. The company is looking forward to launching its products to the podiatry market, supported by 15 years of clinical history and 25 years of National Institutes of Health (NIH) funding and research. Human Amniotic Membrane transplantation has over 100 years of clinical history and has become a standard of care for numerous ophthalmic indications. Cryopreserved Amniotic Membrane (C-AM) has shown regenerative healing properties in ocular surgery by reducing inflammation, pain, scarring and adhesion. Amniox Medical is introducing the unique properties of Cryopreserved Amniotic Membrane to the orthopedic and ...